SCL Science Inc. is engaged in developing and commercializing biomimetic medical hemostatic agents, including BiMM, InnoSeal, Endoseal, Jelly Seal, STOP, and InnoLOCK. The company also offers AI-driven digital healthcare solutions, such as tele-radiology services, personalized health screening, and bio-logistics for temperature-sensitive pharmaceuticals. The company was formerly known as InnoTherapy, Inc. and changed its name to SCL Science Inc. in March 2024. SCL Science Inc. was incorporated in 2010 and is headquartered in Seoul, South Korea.
Headquarters
1210, 1206, 2Cha, Ace Hitech City, 25, Seonyu-Ro 13-Gil, Yeongdeungpo-Gu
Seoul; Seoul;
Contact Details: Purchase the SCL Science Inc. report to view the information.
Website: http://www.innotherapy.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service